Correlation Between Basilea Pharmaceutica and Implenia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Implenia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Implenia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Basilea Pharmaceutica AG and Implenia AG, you can compare the effects of market volatilities on Basilea Pharmaceutica and Implenia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Implenia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Implenia.

Diversification Opportunities for Basilea Pharmaceutica and Implenia

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Basilea and Implenia is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Implenia AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Implenia AG and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Implenia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Implenia AG has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Implenia go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Implenia

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 1.0 times more return on investment than Implenia. However, Basilea Pharmaceutica is 1.0 times more volatile than Implenia AG. It trades about 0.0 of its potential returns per unit of risk. Implenia AG is currently generating about -0.05 per unit of risk. If you would invest  4,550  in Basilea Pharmaceutica AG on September 4, 2024 and sell it today you would lose (455.00) from holding Basilea Pharmaceutica AG or give up 10.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Basilea Pharmaceutica AG  vs.  Implenia AG

 Performance 
       Timeline  
Basilea Pharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Basilea Pharmaceutica AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Implenia AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Implenia AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Implenia is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Basilea Pharmaceutica and Implenia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Basilea Pharmaceutica and Implenia

The main advantage of trading using opposite Basilea Pharmaceutica and Implenia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Implenia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Implenia will offset losses from the drop in Implenia's long position.
The idea behind Basilea Pharmaceutica AG and Implenia AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing